There are more than 20 companies and public sector organisation worldwide racing to find a cure and preventing further spread of the disease.
As you might expect, these companies have seen significant share price increases, bucking the downward trend in the broader market. Biotech firms are normally disadvantaged in market sell-off, perhaps another sign of the unique factors at play.
To the extent that anything on this website constitutes a financial promotion it is exempt from the general prohibition in S21 of FSMA on the basis that the site is only intended for investment professionals as such term is defined in S19 of the Financial Promotions Order. Please note that Pensions for Purpose does not provide consultancy services, advice or personal recommendations on any of the investment opportunities mentioned on the platform. We curate content written by Influencer members and do not endorse any underlying funds.